Earnings


  • Vicarious Surgical plans to seek de novo clearance for its surgical robot.
    Image attribution tooltip
    Permission granted by Vicarious Surgical
    Image attribution tooltip

    Vicarious presses forward with soft tissue robot despite struggles

    The company detailed upcoming milestones for its robotic surgery system on a fourth-quarter earnings call.

    By March 6, 2024
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic estimates up to 40 job losses in Ireland due to restructuring

    The company confirmed the potential job reductions from shutting down its ventilator product lines in an email to MedTech Dive.

    By March 5, 2024
  • A brick building with a sign that says "Henry Schein Inc."
    Image attribution tooltip
    Bruce Bennett via Getty Images
    Image attribution tooltip

    Henry Schein expects cyber incident costs to continue in 2024

    The company reported a $350 million to $400 million reduction in Q4 sales due to the incident, which forced it to take some systems offline. 

    By Feb. 27, 2024
  • A surgeon holds a piece of surgical mesh for hernia and abdominal wall surgery.
    Image attribution tooltip
    Courtesy of Integra
    Image attribution tooltip

    Integra Lifesciences to cut about 60 jobs as it closes Indiana site

    Manufacturing will be transferred to a plant in Maryland as part of a strategy to bolster operational efficiency, a company spokesperson said.

    By Feb. 27, 2024
  • Thaysen is pictured in a suit and tie.
    Image attribution tooltip
    Permission granted by Illumina
    Image attribution tooltip

    Illumina cut 12% of global staff over past year: CEO

    The genomics company, which initiated a fresh round of layoffs last month, expects to finalize its Grail divestiture by the end of June, Jacob Thaysen said Thursday.

    By Feb. 9, 2024
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer Biomet to cut about 540 jobs

    A spokesperson told MedTech Dive that the company will lay off about 3% of its workforce as part of a restructuring. 

    By Updated Feb. 8, 2024
  • A circular device with a metal mesh around it.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    How Edwards’ Evoque valve won an early nod from the FDA

    The heart valve specialist has the chance to shape a new tricuspid market with the first-of-its-kind device, like it did 20 years ago in TAVR, CEO Bernard Zovighian said.

    By Feb. 7, 2024
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific nets Farapulse approval, pushes back US TAVR launch

    The device maker disclosed it will start the highly anticipated launch of the AFib ablation device, but approval for its aortic valve replacement implant will have to wait. 

    By Jan. 31, 2024
  • An empty hospital operating theater is prepared with lighting and equipment
    Image attribution tooltip
    JohnnyGreig via Getty Images
    Image attribution tooltip

    The top medtech trends in 2024

    Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

    By MedTech Dive Staff • Jan. 31, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    What to watch for as Stryker, Boston Scientific and BD post earnings this week

    The next round of results follows reports from J&J, Abbott and Intuitive, all of which signaled a solid end to 2023.

    By Jan. 29, 2024
  • Intuitive Surgical da Vinci robot, surgeon at surgeon console
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Robot reveal: Intuitive submits 510(k) for next-generation system

    The new surgical robot will have 10,000 times the processing power of the current da Vinci model, CEO Gary Guthart said on the company’s fourth-quarter earnings call.

    By Jan. 24, 2024
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott says all four segments stronger than pre-pandemic

    CEO Robert Ford said investing in its base business using COVID-19 testing revenues was “absolutely the right strategy.”

    By Jan. 24, 2024
  • tort liability, earplugs, Aearo Technologies
    Image attribution tooltip
    "3M headquarters" by Acroterion is licensed under CC BY-SA 4.0
    Image attribution tooltip

    3M on track to complete healthcare spinoff in first half of 2024

    The healthcare leadership team will share more details as the completion of the transaction approaches.

    By Jan. 24, 2024
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J expects strong procedure volumes in 2024

    After reporting growth for its procedure-based units in the fourth quarter, J&J forecast surgery volumes to be above pre-pandemic levels this year.

    By Jan. 23, 2024
  • Signs for Johnson & Johnson are seen on company offices in California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    3 bellwether companies to watch as medtech earnings season begins

    J&J, Intuitive Surgical and Abbott kick off this week with fourth-quarter reports.

    By Jan. 22, 2024
  • Intuitive Surgical CEO Gary Guthart
    Image attribution tooltip
    Permission granted by Intuitive Surgical
    Image attribution tooltip

    Intuitive CEO: Strong robot placements offset bariatric surgery slowdown

    Speaking at the J.P. Morgan Healthcare Conference, CEO Gary Guthart said the robotics company is also seeing strong growth in general surgeries.

    By Jan. 11, 2024
  • Masimo's W1 health watch
    Image attribution tooltip
    Courtesy of Masimo
    Image attribution tooltip

    Masimo’s preliminary Q4 results, 2024 outlook exceed analyst expectations

    Analysts see the update as evidence Masimo may be rebounding after failing to meet their expectations earlier in the year.

    By Jan. 11, 2024
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip
    Deep Dive

    5 medtech trends to watch in 2024

    From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.

    By Jan. 9, 2024
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards to spin off its critical care business

    Edwards is the latest healthcare firm to spin off a business to focus on specific markets, following larger companies like Johnson & Johnson and GE.

    By Dec. 8, 2023
  • layoffs
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Roundup: Top medtech companies cut jobs in 2023

    Johnson & Johnson, Medtronic and Abbott were among the top companies to announce layoffs this year as the industry implemented cost-cutting measures.

    By Nov. 27, 2023
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic CEO downplays the impact of obesity drugs on bariatric surgeries, diabetes unit

    The company is the latest medtech to address concerns about how weight loss drugs may impact growth.

    By Nov. 21, 2023
  • A street sign marks the intersection of Wall and Broad Streets in Manhattan.
    Image attribution tooltip
    rabbit75_ist/iStock/Getty Images Plus via Getty Images
    Image attribution tooltip

    Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown

    Despite these challenges, companies also flagged improvements in supply chain dynamics and pricing that could boost their earnings.

    By Updated Nov. 21, 2023
  • A person wearing safety goggles holds a pipette of fluid.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    Illumina explores options for Grail, hires advisers

    The company, facing pressure from regulators to divest Grail, also formed a special committee to speed decisions on the fate of the liquid biopsy test maker.

    By Nov. 10, 2023
  • An oversized pair of scissors looms over seven workers sitting in office chairs suspended by strings.
    Image attribution tooltip
    mathisworks via Getty Images
    Image attribution tooltip

    Acutus laying off 65% of employees to focus solely on Medtronic heart device deal

    The company has decided to exit the mapping and ablation business and focus its remaining cash on the Medtronic partnership.

    By Nov. 10, 2023
  • An operating room has a table surrounded by screens and several overhead lights, and a surgical robot that says "Mako"
    Image attribution tooltip
    Permission granted by Stryker
    Image attribution tooltip

    4 takeaways from Stryker’s investor day

    The company’s expected return to pre-pandemic operating margins, procedure backlogs and weight loss drugs were among the topics discussed at Wednesday’s event.

    By Nov. 9, 2023